undamentalytics Newsletter
Sign in

Cardio Diagnostics Holdings, Inc. cash flow statement

In fiscal 2025, Cardio Diagnostics Holdings, Inc.'s operations generated −$5.7m of cash; it spent $187,317 on capital projects, leaving free cash flow of −$5.9m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−1−5−6−5−6−6
Depreciation and amortisation000000
Stock-based pay001300
Capital spending——1000
Free cash flow——−6−5−6−6
Free cash flow after stock pay——−8−8−6−6
Shares issued112—1244

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: CDIO vs CUPRCDIO vs HSCSCDIO vs POAS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cardio Diagnostics Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cardio Diagnostics Holdings, Inc.